Coeptis Therapeutics (COEPW) Competitors $0.03 +0.00 (+1.01%) As of 05/30/2025 02:19 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock COEPW vs. ATNFW, SXTPW, DRTSW, WENAW, APLMW, BCTXW, CDIOW, CTCXW, CELUW, and CEROWShould you be buying Coeptis Therapeutics stock or one of its competitors? The main competitors of Coeptis Therapeutics include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Celularity (CELUW), and CERo Therapeutics (CEROW). These companies are all part of the "biotechnology" industry. Coeptis Therapeutics vs. 180 Life Sciences 60 Degrees Pharmaceuticals Alpha Tau Medical Anew Medical Apollomics BriaCell Therapeutics Cardio Diagnostics Carmell Celularity CERo Therapeutics 180 Life Sciences (NASDAQ:ATNFW) and Coeptis Therapeutics (NASDAQ:COEPW) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, institutional ownership, risk, media sentiment, dividends, analyst recommendations, community ranking and profitability. Does the media favor ATNFW or COEPW? In the previous week, 180 Life Sciences and 180 Life Sciences both had 1 articles in the media. 180 Life Sciences' average media sentiment score of 1.89 equaled Coeptis Therapeutics'average media sentiment score. Company Overall Sentiment 180 Life Sciences Very Positive Coeptis Therapeutics Very Positive Which has stronger valuation & earnings, ATNFW or COEPW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/ACoeptis Therapeutics$62.87KN/AN/AN/AN/A Is ATNFW or COEPW more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A Coeptis Therapeutics N/A N/A N/A Does the MarketBeat Community believe in ATNFW or COEPW? 180 Life Sciences and Coeptis Therapeutics both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperform180 Life SciencesN/AN/ACoeptis TherapeuticsN/AN/A SummaryCoeptis Therapeutics beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks. Get Coeptis Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for COEPW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart COEPW vs. The Competition Export to ExcelMetricCoeptis TherapeuticsBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$127.85M$5.42B$8.41BDividend YieldN/A3.74%5.28%4.17%P/E RatioN/A3.3227.0519.79Price / SalesN/A4,416.08406.30134.00Price / CashN/A13.1938.2534.64Price / BookN/A33.566.744.50Net IncomeN/A-$91.56M$3.23B$248.30M7 Day PerformanceN/A0.57%1.22%0.99%1 Month PerformanceN/A3.45%5.99%7.48%1 Year PerformanceN/A168.05%25.78%8.72% Coeptis Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)COEPWCoeptis TherapeuticsN/A$0.03+1.0%N/A+35.3%$0.00$62,874.000.004Positive NewsATNFW180 Life SciencesN/A$0.01-6.3%N/A+11.1%$0.00N/A0.007Positive NewsSXTPW60 Degrees PharmaceuticalsN/A$0.05-8.8%N/A-18.1%$0.00$607,574.000.002Gap DownDRTSWAlpha Tau MedicalN/A$0.25+3.3%N/A-10.8%$0.00N/A0.0080Gap UpWENAWAnew MedicalN/A$0.04-0.3%N/AN/A$0.00N/A0.00N/AGap DownAPLMWApollomicsN/A$0.02+34.0%N/AN/A$0.00N/A0.0059News CoverageShort Interest ↑Gap DownHigh Trading VolumeBCTXWBriaCell TherapeuticsN/A$0.10-22.8%N/A-82.2%$0.00N/A0.008Positive NewsShort Interest ↓CDIOWCardio DiagnosticsN/A$0.02+14.3%N/A-66.3%$0.00$34,890.000.007Short Interest ↓Gap DownHigh Trading VolumeCTCXWCarmellN/A$0.03+6.8%N/A-71.7%$0.00$32,839.000.0014Gap UpCELUWCelularityN/A$0.04-17.2%N/A+100.5%$0.00$54.22M0.00220Positive NewsGap UpCEROWCERo TherapeuticsN/A$0.02+42.9%N/A-64.0%$0.00N/A0.008Short Interest ↑ Related Companies and Tools Related Companies ATNFW Competitors SXTPW Competitors DRTSW Competitors WENAW Competitors APLMW Competitors BCTXW Competitors CDIOW Competitors CTCXW Competitors CELUW Competitors CEROW Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:COEPW) was last updated on 6/1/2025 by MarketBeat.com Staff From Our PartnersDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredThe “supermetal” that could power AIWhile the headlines focus on AI models and chip speed, Elon Musk is investing in the material side of the stor...True Market Insiders | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredMidnight trade alert: After-hours spike incoming??? Most traders don’t realize this… But the closing bell means jack $#!&. They hear the bell and they think...Timothy Sykes | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coeptis Therapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Coeptis Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy COEPW Stock Free COEPW Stock Alerts